✦ LIBER ✦

Anti-IL-2-R monoclonal antibody in allograft recipients

✍ Scribed by Soulillou, J.P.; Le Mauff, B.; Cantarovich, D.; Giral, M.; Hourmant, M.; Jacques, Y.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and immunodynamics of c

✍ J. M. Kovarik; E. Rawlings; P. Sweny; O. Fernando; R. Moore; P. J. Griffin; P. F 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 179 KB

Immunological effects of the anti-IL-2 r

✍ B Nashan; R Schwinzer; HJ Schlitt; K Wonigeit; R Pichlmayr 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 767 KB

Safety Profile, Pharmacokinetics, and Ph

✍ T.L. Pruett; R.W. McGory; F.H. Wright; M.D. Pescovitz; H. Yang; J.B. McClain 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 448 KB

Anti-idiotypic antibodies in heart and k

✍ Reed, E.; Xi, Y.P.; Sun, Y.K.; Suciu-Foca, N. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Basiliximab-Chimeric anti-IL2-R monoclon

✍ N.E.M Gibelli; M.L Pinho-Apezzato; H.T Miyatani; J.G Maksoud-Filho; M.M Silva; A 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Anti-IL-15 monoclonal antibody effective

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB